These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 16585190)

  • 21. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. VEGF increases the fibrinolytic activity of endothelial cells within fibrin matrices: involvement of VEGFR-2, tissue type plasminogen activator and matrix metalloproteinases.
    Ratel D; Mihoubi S; Beaulieu E; Durocher Y; Rivard GE; Gingras D; Béliveau R
    Thromb Res; 2007; 121(2):203-12. PubMed ID: 17512973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
    Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
    Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon-beta is a potent inducer of interferon regulatory factor-1/2-dependent IP-10/CXCL10 expression in primary human endothelial cells.
    Buttmann M; Berberich-Siebelt F; Serfling E; Rieckmann P
    J Vasc Res; 2007; 44(1):51-60. PubMed ID: 17167270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 15(S)-hydroxyeicosatetraenoic acid-induced angiogenesis requires STAT3-dependent expression of VEGF.
    Srivastava K; Kundumani-Sridharan V; Zhang B; Bajpai AK; Rao GN
    Cancer Res; 2007 May; 67(9):4328-36. PubMed ID: 17483346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Osteopontin induces angiogenesis through activation of PI3K/AKT and ERK1/2 in endothelial cells.
    Dai J; Peng L; Fan K; Wang H; Wei R; Ji G; Cai J; Lu B; Li B; Zhang D; Kang Y; Tan M; Qian W; Guo Y
    Oncogene; 2009 Sep; 28(38):3412-22. PubMed ID: 19597469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. VEGF and inhibitors of TGFbeta type-I receptor kinase synergistically promote blood-vessel formation by inducing alpha5-integrin expression.
    Liu Z; Kobayashi K; van Dinther M; van Heiningen SH; Valdimarsdottir G; van Laar T; Scharpfenecker M; Löwik CW; Goumans MJ; Ten Dijke P; Pardali E
    J Cell Sci; 2009 Sep; 122(Pt 18):3294-302. PubMed ID: 19706683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of angiogenic tubule formation and induction of apoptosis in human endothelial cells by the selective cyclooxygenase-2 inhibitor 5-bromo-2-(4-fluorophenyl)-3-(methylsulfonyl) thiophene (DuP-697).
    Churchman A; Baydoun AR; Hoffman R
    Eur J Pharmacol; 2007 Nov; 573(1-3):176-83. PubMed ID: 17643408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Angiogenic effect of saponin extract from Panax notoginseng on HUVECs in vitro and zebrafish in vivo.
    Hong SJ; Wan JB; Zhang Y; Hu G; Lin HC; Seto SW; Kwan YW; Lin ZX; Wang YT; Lee SM
    Phytother Res; 2009 May; 23(5):677-86. PubMed ID: 19107746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.
    Fukushima K; Miyamoto S; Tsukimori K; Kobayashi H; Seki H; Takeda S; Kensuke E; Ohtani K; Shibuya M; Nakano H
    Biol Reprod; 2005 Jul; 73(1):172-9. PubMed ID: 15788755
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stat1 negatively regulates angiogenesis, tumorigenicity and metastasis of tumor cells.
    Huang S; Bucana CD; Van Arsdall M; Fidler IJ
    Oncogene; 2002 Apr; 21(16):2504-12. PubMed ID: 11971185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells.
    Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE
    Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pigment epithelium-derived factor downregulates vascular endothelial growth factor (VEGF) expression and inhibits VEGF-VEGF receptor 2 binding in diabetic retinopathy.
    Zhang SX; Wang JJ; Gao G; Parke K; Ma JX
    J Mol Endocrinol; 2006 Aug; 37(1):1-12. PubMed ID: 16901919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.
    Dardik R; Inbal A
    Exp Cell Res; 2006 Oct; 312(16):2973-82. PubMed ID: 16914140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiogenic activity of swine granulosa cells: effects of hypoxia and vascular endothelial growth factor Trap R1R2, a VEGF blocker.
    Bianco F; Basini G; Grasselli F
    Domest Anim Endocrinol; 2005 Apr; 28(3):308-19. PubMed ID: 15760671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling.
    Paulus C; Krauss S; Nevels M
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3840-5. PubMed ID: 16497831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells.
    Badamtseren B; Odkhuu E; Koide N; Haque A; Naiki Y; Hashimoto S; Komatsu T; Yoshida T; Yokochi T
    Cell Immunol; 2011; 270(1):19-24. PubMed ID: 21477797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola.
    Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of angiogenesis by the plant alkaloid, sanguinarine.
    Eun JP; Koh GY
    Biochem Biophys Res Commun; 2004 Apr; 317(2):618-24. PubMed ID: 15063803
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The recombinant kringle domain of urokinase plasminogen activator inhibits VEGF165-induced angiogenesis of HUVECs by suppressing VEGFR2 dimerization and subsequent signal transduction.
    Kim BM; Lee DH; Choi HJ; Lee KH; Kang SJ; Joe YA; Hong YK; Hong SH
    IUBMB Life; 2012 Mar; 64(3):259-65. PubMed ID: 22252975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.